IP Library › Assignment 027015/0765
Patent Assignment
Reel/Frame 027015/0765

Security Agreement

Recorded: 2011-10-04 Pages: 10
Assignor
JUVARIS BIOTHERAPEUTICS, INC.
Executed: 2011-09-06
Assignee
TRIPLEPOINT CAPITAL LLC
2755 SAND HILL ROAD, MENLO PARK, CALIFORNIA, 94025
Covered Properties (25)
Use of Immunogenic Compositions for the Treatment or Prevention of Pathogen Infections
Enhancement of an Immune Response by Administration of a Cationic Lipid-Dna Complex (Cldc)
Improved Methods for the Preparation of Amphiphilic Nitrogen Containing Imidazolinium Derivative Compounds
Subunit Vaccines for Herpes Viruses and Methods of Use
Amphiphilic Nitrogen Containing Imidazolinium Derivative Compounds and Uses
Patent: 5,705,655 →
Application: 08/247,963 →
Cationic Lipid: Dna Complexes for Gene Targeting
Patent: 5,830,878 →
Application: 08/485,005 →
Methods for Purifying Nucleic Acids
Patent: 6,011,148 →
Application: 08/691,090 →
Amphiphilic Imidazolinium Derivatives
Patent: 5,736,395 →
Application: 08/858,571 →
Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
Patent: 6,693,086 →
Application: 09/104,759 →
Methods for Purifying Nucleic Acids
Patent: 7,807,822 →
Application: 09/121,798 →
Publication: US 2002/0198372
Cationic Lipid:Dna Complexes for Gene Targeting
Patent: 6,344,446 →
Application: 09/184,771 →
Process and Equipment for Plasmid Purification
Patent: 7,026,468 →
Application: 09/774,284 →
Publication: US 2001/0034435
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Patent: 7,314,746 →
Application: 10/527,618 →
Publication: US 2006/0166331
Methods of Using Nucleic Acid Vector-Lipid Complexes
Patent: 7,741,300 →
Application: 11/320,019 →
Publication: US 2006/0223769
Process and Equipment for Plasmid Purfication
Patent: 8,236,495 →
Application: 11/327,987 →
Publication: US 2006/0106208
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Patent: 7,771,945 →
Application: 11/965,607 →
Publication: US 2008/0102519
Vaccines Using Nucleic Acid-Lipid Complexes
Application: 12/399,896 →
Publication: US 2009/0162427
Enhancement of an Immune Response by Administration of a Cationic Lipid-DNA Complex (CLDC)
Patent: 8,945,590 →
Application: 12/411,377 →
Publication: US 2009/0263423
Methods for the Preparation of Amphillic Nitrogen Containing Imidazolinium Derivative Compounds
Patent: 8,044,215 →
Application: 12/432,660 →
Publication: US 2010/0280258
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
Application: 12/563,012 →
Publication: US 2010/0086584
Methods for Purifying Nucleic Acids
Patent: 8,680,261 →
Application: 12/796,961 →
Publication: US 2010/0248336
Apparatus and Method for Preparative Scale Purification of Nucleic Acids
Patent: 8,158,348 →
Application: 12/850,969 →
Publication: US 2011/0070638
Enhancement of Adaptive Immune Response by Systemic Administration of an Immunostimulant
Application: 61/039,381 →
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
Application: 61/098,005 →
Subunit Vaccines for Herpes Viruses and Methods of Use
Application: 61/308,856 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 1996
From: HEATH, TIMOTHY D.; SOLODIN, IGOR
To: MEGABIOS CORPORATION
Reel/Frame 007770/0090 →
Assignment of Assignor's Interest Oct 15, 1996
From: BUSSEY, LEE B.; ADAMSON, ROBERT; ATCHLEY, ALAN
To: MEGABIOS CORPORATION
Reel/Frame 008214/0198 →
Assignment of Assignor's Interest May 4, 1998
From: MCCLARRINON, MOLLY
To: MEGABIOS CORPORATION
Reel/Frame 009160/0102 →
Assignment of Assignor's Interest May 4, 1998
From: GORMAN, CORI M.
To: MEGABIOS CORPORATION
Reel/Frame 009159/0727 →
Assignment of Assignor's Interest Jun 25, 1998
From: DOW, STEVEN W.; ELMSLIE, ROBYN E.; SCHWARZE, JURGEN KARL JOHANNES
To: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
Reel/Frame 009295/0130 →
Assignment of Assignor's Interest Oct 5, 1998
From: BRIDENBAUGH, ROBERT; DANG, WARREN; BUSSEY, LEE B.
To: MEGABIOS CORPORATION
Reel/Frame 009495/0308 →
Merger Jul 26, 1999
From: MEGABIOS CORPORATION
To: VALENTIS, INC.
Reel/Frame 010114/0255 →
Certificate of Ownership and Merger Sep 23, 1999
From: MEGABIOS CORPORATION
To: VALENTIS, INC.
Reel/Frame 010247/0566 →
Merger & Change of Name Apr 19, 2001
From: GENEMEDICINE, INC.
To: VALENTIS, INC.
Reel/Frame 011742/0594 →
Assignment of Assignor's Interest Nov 21, 2002
From: GELFAND, ERWIN W.
To: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
Reel/Frame 013517/0189 →
Assignment of Assignor's Interest Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0920 →
Assignment of Assignor's Interest Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0922 →
Assignment of Assignor's Interest Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0918 →
Merger Dec 11, 2008
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 021962/0897 →
Assignment of Assignor's Interest Dec 11, 2008
From: URIGEN PHARMACEUTICALS, INC.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 021962/0916 →
Security Agreement Feb 2, 2009
From: URIGEN PHARMACEUTICALS, INC.; URIGEN N.A., INC.
To: PLATINUM-MONTAUR LIFE SCIENCES, LLC
Reel/Frame 022327/0001 →
Assignment of Assignor's Interest May 27, 2009
From: YU, CHENG-SEIN; BUSSEY, LEE B.
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 022741/0754 →
Assignment of Assignor's Interest Jul 8, 2009
From: FAIRMAN, JEFFERY; VAUGHN, MARLA LAY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 022931/0408 →
Assignment of Assignor's Interest Dec 17, 2009
From: CALLEJO, BERNADETTE; MONATH, TOM; FAIRMAN, JEFFERY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 023672/0190 →
Merger Oct 6, 2010
From: VALENTIS, INC.
To: URIGEN PHARMACEUTICALS, INC.
Reel/Frame 025095/0274 →
Assignment of Assignor's Interest Mar 25, 2013
From: FAIRMAN, JEFFERY
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 030079/0226 →
Assignment of Assignor's Interest Mar 25, 2013
From: COHEN, GARY; EISENBERG, ROSELYN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 030079/0187 →
Release of Security Interest Oct 6, 2015
From: TRIPLEPOINT CAPITAL LLC
To: JUVARIS BIOTHERAPEUTICS, INC.
Reel/Frame 036739/0195 →